This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Humana's Initiatives to Help Dental Providers Manage Costs
by Zacks Equity Research
Humana (HUM) takes certain measures to provide cushion to dental care providers in coping with high costs during the plaguing pandemic.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Centene vs. Anthem: Which is a Better-Positioned Stock?
by Zacks Equity Research
Centene (CNC) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On comparative evaluation, we try to discover which is a more profitable bet based on fundamentals.
Molina Healthcare (MOH) Continues to Waive Coronavirus Expenses
by Zacks Equity Research
Molina Healthcare (MOH) continues to reduce "out-of-pocket" expenses related to coronavirus treatment for its members and undertakes several other initiatives.
UnitedHealth to Aid Eligible Medicaid Members in Kentucky
by Zacks Equity Research
UnitedHealth (UNH) and Commonwealth of Kentucky intends to improve health outcomes of Medicaid members in Kentucky, where it already has a strong presence.
Why Should You Hold on to Centene Stock in Your Portfolio?
by Zacks Equity Research
Riding high on a healthy revenue stream and a solid 2020 guidance, Centene (CNC) holds potential to benefit its investors.
Humana's Unit to Launch Primary Care Centers for Seniors
by Zacks Equity Research
Humana's (HUM) arm Partners in Primary Care to unveil 20 new medical care centers with focus to serve seniors. There are further plans to extend reach in Houston with 10 more centers.
Molina Healthcare's New Deal to Boost Its Medicaid Business
by Zacks Equity Research
Molina Healthcare's (MOH) new agreement intends to efficiently serve its Medicaid members, which, in turn, will likely boost its market presence.
4 Health Insurance Companies in the Spotlight Right Now
by Zacks Equity Research
Based on a few positives, we narrowed down to four health insurers that deserve to be in your focus despite the COVID-19 crisis.
Humana Contract Renewal to Aid Medicaid Members in Kentucky
by Zacks Equity Research
Humana's (HUM) new agreement intends to efficiently serve Medicaid members of Kentucky, where it already boasts of a strong base.
Why Is Molina (MOH) Up 13.3% Since Last Earnings Report?
by Zacks Equity Research
Molina (MOH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is JPMorgan Diversified Return U.S. Mid Cap Equity ETF (JPME) a Strong ETF Right Now?
by Sweta Killa
Smart Beta ETF report for JPME
Why Should You Retain Molina Healthcare in Your Portfolio?
by Zacks Equity Research
Riding high on its growing revenues and financial strength, Molina Healthcare (MOH) has potential to reap benefits to its investors.
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Banking on its sturdy membership and inorganic growth profile, Anthem (ANTM) holds potential to reap benefits for investors.
Magellan (MGLN) Q1 Earnings Top on Lower Medical Utilization
by Zacks Equity Research
Magellan Health's (MGLN) Q1 earnings benefit from higher profit owing to lower utilization of elective procedures.
Has Molina Healthcare (MOH) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Will Molina Healthcare Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Molina Healthcare
Molina Healthcare (MOH) Q1 Earnings Miss Mark, Slip Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) Q1 results reflect high expenses and low net income.
Molina (MOH) Lags Q1 Earnings Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of -0.33% and 2.74%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Molina Healthcare (MOH) This Earnings Season?
by Zacks Equity Research
Molina Healthcare (MOH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Centene's (CNC) Q1 Earnings Miss Estimates, Decline Y/Y
by Zacks Equity Research
Centene's (CNC) Q1 results reflect muted earnings due to lower investment income and incremental senior note interest expense.
Will Membership Growth Drive Cigna's (CI) Earnings in Q1?
by Zacks Equity Research
Cigna's (CI) Q1 earnings are likely to have been aided by revenue growth in various segments.